title: Refractory neurosarcoidosis responding to infliximab.
authors.affiliation: Department of Clinical Neurosciences, University of Calgary, Foothills Hospital, Calgary, Alberta, Canada. jacqueline.pettersen@calgaryhealthregion.ca
authors.forename: J A
authors.initials: JA
authors.lastname: Pettersen
authors.forename: D W
authors.initials: DW
authors.lastname: Zochodne
authors.forename: R B
authors.initials: RB
authors.lastname: Bell
authors.forename: L
authors.initials: L
authors.lastname: Martin
authors.forename: M D
authors.initials: MD
authors.lastname: Hill
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001921:Brain / Q000473:pathology; D001927:Brain Diseases / Q000188:drug therapy* / Q000473:pathology; D001929:Brain Edema / Q000188:drug therapy / Q000209:etiology / Q000473:pathology; D004351:Drug Resistance; D006099:Granuloma / Q000473:pathology; D006801:Humans; D000069285:Infliximab; D008111:Liver Function Tests; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D012507:Sarcoidosis / Q000188:drug therapy* / Q000473:pathology
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab; D011241:Prednisone